Park, Sat Byul, Kim, Kyu-Nam, Sung, Eunju et al. · Biological & pharmaceutical bulletin · 2016 · DOI
Researchers tested whether injections of human placental extract (a substance derived from placentas) could help people with ME/CFS feel less fatigued. Seventy-eight people with chronic fatigue received either the placental extract or a placebo (dummy injection) three times per week for 6 weeks. Those who received the real extract reported greater improvements in fatigue levels compared to the placebo group, though the benefit was only seen in people with ME/CFS, not in those with other types of chronic fatigue.
This study provides evidence from a well-designed RCT that a specific biologic intervention may benefit ME/CFS patients, a population with limited treatment options and significant quality-of-life burden. The finding that HPE showed benefits in ME/CFS but not idiopathic chronic fatigue suggests potential disease-specific mechanisms that warrant further investigation.
This study does not establish the mechanism by which HPE works or whether benefits persist beyond 6 weeks. The restriction to a single geographic region and the small sample size mean these results may not generalize to all ME/CFS populations. Statistically significant improvement in symptom scales does not necessarily translate to clinically meaningful functional recovery.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →